The phagocyte NADPH oxidase mediates oxidative microbial killing in granulocytes and macrophages. However, because the reactive oxygen species produced by the NADPH oxidase can also be toxic to the host, it is essential to control its activity. Little is known about the endogenous mechanism(s) that limits NADPH oxidase activity. Here, we demonstrate that the myeloid-inhibitory receptor SIRPa acts as a negative regulator of the phagocyte NADPH oxidase. Phagocytes isolated from SIRPa mutant mice were shown to have an enhanced respiratory burst. Furthermore, overexpression of SIRPa in human myeloid cells prevented respiratory burst activation. The inhibitory effect required interactions between SIRPa and its natural ligand, CD47, as well as signaling through the SIRPa cytoplasmic immunoreceptor tyrosine-based inhibitory motifs. Suppression of the respiratory burst by SIRPa was caused by a selective repression of gp91 phox expression, the catalytic component of the phagocyte NADPH oxidase complex. Thus, SIRPa can limit gp91 phox expression during myeloid development, thereby controlling the magnitude of the respiratory burst in phagocytes.
INTRODUCTION
One of the most important antimicrobial activities of phagocytes is the abrupt formation of reactive oxygen species (ROS), a process known as the respiratory burst. This is mediated by the phagocyte NADPH oxidase complex, and its importance is best illustrated by patients with chronic granulomatous disease (CGD) and dysfunctional NADPH oxidase, and as a result are hypersusceptible to a variety of bacterial and fungal infections (Roos et al., 2003; Bedard and Krause, 2007) . The phagocyte NADPH oxidase is a multisubunit enzyme complex composed of (1) the membrane proteins gp91 phox (NOX2, the catalytic component of the oxidase) and p22 phox ; (2) the cytosolic proteins p40 phox , p47 phox , and p67 phox ; and (3) the small GTPase Rac.
Activation of the oxidase involves translocation of the cytosolic subunits p40 phox , p47 phox , p67 phox , and Rac to the plasma membrane and assembly of the oxidase complex. Once assembled, the NADPH oxidase generates superoxide (O 2 À ) formation by transferring electrons from NADPH in the cytosol over the plasma membrane to molecular oxygen. Superoxide produced by the oxidase forms the basic compound from which other ROS, such as hydrogen peroxide (H 2 O 2 ) and hypochlorous acid (HOCl), are formed. High concentrations of ROS are directly toxic to microbes, and may also be indirectly toxic due to the liberation of hydrolytic proteases (Reeves et al., 2002) .
The mechanisms of NADPH oxidase activation have been relatively well characterized, but essentially nothing is known about whether and how the magnitude of the respiratory burst is controlled. The latter is important because ROS not only play a critical role in host defense but can also be toxic to the host. The tight control over NADPH oxidase activity is illustrated in part by the observation that there is only very little interindividual variation in the respiratory burst (Zhao et al., personal communication) . The magnitude of the respiratory burst is likely to be primarily determined by the protein expression levels of the various NADPH oxidase components, which are expressed in a developmentally regulated fashion in phagocytes. Although the developmental pathways and transcription factors that trigger the expression of the different NADPH oxidase components during myeloid development have been established (Lindsey et al., 2007; Zhu et al., 2008; Kautz et al., 2001) , the putative regulatory mechanisms that counterbalance these factors and prevent excessive, potentially harmful expression of the various NADPH oxidase components within phagocytes have remained unknown.
SIRPa is an inhibitory immunoreceptor that is predominantly expressed on myeloid and neuronal cells (Fujioka et al., 1996; Adams et al., 1998) . The cytoplasmic region of SIRPa contains four immunoreceptor tyrosine-based inhibitory motifs (ITIMs) that upon ligand binding become phosphorylated and mediate the recruitment and activation of the SH2-domain-containing tyrosine phosphatases (PTPase) SHP-1 and SHP-2. SHP-1 and SHP-2 can in turn dephosphorylate specific protein substrates and thereby mediate various biological functions, generally in a negative fashion. The N-terminal V-like Ig domain mediates recognition of the broadly expressed transmembrane glycoprotein CD47 (Jiang et al., 1999; Seiffert et al., 1999; Vernon-Wilson et al., 2000; Liu et al., 2007; Lee et al., 2007; Hatherley et al., 2008) . SIRPa has been implicated in the regulation of a number of functions in myeloid cells (van Beek et al., 2005; Barclay and Brown, 2006) . One of the best-documented functions of SIRPa is its inhibitory role in the phagocytosis of host cells by macrophages. In particular, the ligation of SIRPa on macrophages by the ''don't eat me'' signal CD47 expressed on host cells, such as erythrocytes and platelets, generates an inhibitory signal that negatively regulates phagocytosis (Oldenborg et al., 2000; Yamao et al., 2002) . This suggests that CD47 acts as a molecular signature of self that limits immune-mediated damage against normal and healthy host cells during infection and inflammation by interacting with the self sensor SIRPa on phagocytes and other myeloid cells. However, until now, a direct involvement of CD47-SIRPa interactions in the regulation of inflammatory mediators and antimicrobial functions has not been reported.
Here we demonstrate that SIRPa acts as a critical negative regulator of the respiratory burst. Inhibition of the phagocyte 
RESULTS AND DISCUSSION
Enhanced NADPH Oxidase Activity in SIRPa Mutant Phagocytes To investigate whether SIRPa signaling regulates the phagocyte NADPH oxidase, we performed studies with cells from SIRPa mutant mice. These mice express a SIRPa molecule lacking the cytoplasmic tail and signaling capacity (Yamao et al., 2002) . We sorted distinct bone-marrow cell populations of SIRPa mutant and control mice, including granulocytes, monocytes, immature myeloid cells, and lymphoid cells, by fluorescence-activated cell sorting (FACS) using CD31 and Ly-6C as markers ( Figure 1A ) as described previously (Nikolic et al., 2003) , and analyzed their phorbol myristate acetate (PMA)-induced respiratory burst. As reported previously (van Beek et al., 2009) , there were no detectable differences in bone-marrow composition between the mutant and control mice, essentially excluding a prominent nonredundant role of SIRPa signaling in myeloid differentiation. We observed a significantly (50%-75%) enhanced respiratory burst activity in granulocytes and monocytes from SIRPa mutant mice in comparison with cells from wild-type (WT) mice ( Figure 1B) . A similar difference was seen in bone-marrow-derived macrophages ( Figure 1C ). The respiratory burst in immature myeloid cells ( Figure 1B ) appeared unaffected. A comparison of WT and SIRPa mutant mice showed that the production of other inflammatory mediators, including nitric oxide (NO), tumor necrosis factor a (TNFa), interleukin 1b (IL1b), IL6, and IL10, by bonemarrow-derived macrophages in response to lipopolysaccharide (LPS) was not significantly affected ( Figure S1 ). Collectively, these data indicate a selective inhibitory role for SIRPa signaling in the regulation of the respiratory burst.
The lack of difference between WT and SIRPa mutant phagocytes appears to be in contrast to previous reports (Kong et al., 2007; Dong et al., 2008) , in which knockdown of SIRPa in macrophages was shown to enhance cytokine production in response to TLR ligands. A possible explanation for this apparent discrepancy is that inhibition of cytokine production can only be caused by a complete absence of SIRPa, and not by selective deletion of its cytoplasmic tail. A more trivial explanation could relate to differences in the method used for interference. We used macrophages from gene-targeted knockout mice, whereas the other studies used small hairpin RNA (shRNA)-and small interfering RNA (siRNA)-mediated knockdown, which may have triggered macrophage danger pathways that contributed to the response (Stacey et al., 2000) . Our current findings essentially exclude a regulatory role for SIRPa signaling in TLR-induced cytokine production, and support the idea that SIRPa signaling regulates selected inflammatory mediators, such as ROS.
SIRPa Overexpression Inhibits the NADPH Oxidase in Human Phagocytic Cells
To investigate the mechanism by which SIRPa regulates the phagocyte respiratory burst, we tested the effect of overexpression of SIRPa in human myeloid PLB-985 cells. PLB-985 cells are suitable for studying NADPH oxidase activity (Zhen et al., 1993) , and were found to express relatively low levels of endogenous SIRPa as shown by western blotting ( Figure S2A ) and flow cytometry ( Figure S4A ). A chimeric rat-human SIRPa protein was expressed in PLB-985 cells because it allows for selective monitoring and manipulation by the agonistic monoclonal antibody (mAb) ED9 specifically directed against the rat SIRPa extracellular domain (Adams et al., 1998; Alblas et al., 2005) . PLB-985 cells, or mutants with a targeted mutation of the gp91 phox gene (PLB-985 X-CGD; Zhen et al., 1993) , were retrovirally transduced with full-length chimeric rat-human SIRPa protein (SIRPa-WT) or a SIRPa deletion mutant (SIRPa-D87) that is unable to signal because it lacks the cytoplasmic tail. A flow-cytometric analysis showed that the levels of SIRPa expression were comparable for the different cell lines generated ( Figure 2A ) and similar to those generally seen in rat myeloid cell lines or primary rat myeloid cells, such as macrophages or granulocytes (Adams et al., 1998 ; not shown). Western blotting with an antibody against the cytoplasmic tail of SIRPa identified both endogenous and chimeric SIRPa proteins, and confirmed that SIRPa-D87 cells express a truncated SIRPa ( Figure S2A ). We studied the respiratory burst in the different PLB-985 cells after in vitro granulocytic or monocytic differentiation using dimethylformamide (DMF) or vitamin D3 (VitD3), respectively. PMA-induced NADPH oxidase activity was normal in control cells but was abolished in cells expressing WT SIRPa (Figures 2B and 2C) . This effect occurred after either granulocytic or monocytic differentiation. Clearly, the inhibitory effect was not observed in the SIRPa-D87 mutant, suggesting that SIRPa signaling was required. In fact, the SIRPa-D87 cells generated a considerably higher response than the empty vector cells, suggesting that the mutant SIRPa protein acted as a dominant-negative protein by competing with, e.g., endogenous SIRPa for CD47 binding (see below). Of importance, all responses were entirely attributable to the gp91 phox (NOX2)-containing phagocyte NADPH oxidase, because they were completely absent in the PLB-985 X-CGD cells, which have a targeted mutation of the gp91 phox -encoding CYBB gene. Among several other tested stimuli of NADPH oxidase activation (i.e., serum-treated zymosan [STZ] , formyl-methionyl-leucyl-phenylalanine [fMLP], and human IgG complexes), only STZ generated a measurable response in the PLB-985 cells, and again this was completely abrogated by SIRPa-WT expression ( Figure S2B ). This is consistent with a generalized effect of SIRPa on the NADPH oxidase.
SIRPa Selectively Represses gp91 phox Expression during Myeloid Differentiation
Activation of the multisubunit NADPH oxidase complex requires assembly of its individual components, which are expressed during myeloid differentiation (Roos et al., 2003) . To establish the basis for SIRPa-dependent regulation of the respiratory burst, we investigated the expression levels of the different components of the NADPH oxidase complex upon myeloid differentiation. Expression of the membrane component gp91 phox , which forms the enzymatic core of the phagocyte NADPH oxidase, was evaluated in undifferentiated or granulocytic or monocytic differentiated PLB-985 cells by western blotting. The differentiation-induced rise in gp91 phox expression was completely absent in cells that express the full-length SIRPa protein (SIRPa-WT; Figure 2D ). The same was observed when surface levels of gp91 phox were analyzed by flow cytometry with 7D5 mAb ( Figure S3A ). Also, the enhanced respiratory burst activity in cells that express the truncated receptor (SIRPa-D87) was associated with a higher gp91 phox expression. Of importance, the levels of two other NADPH oxidase components, p67 phox and p47 phox , remained unaffected by overexpression of full-length or truncated SIRPa ( Figure 2D ), suggesting that SIRPa was selectively regulating gp91 phox expression. However, the similar levels of upregulation of p47 and p67 observed in the empty vector, SIRPa-WT, and SIRPa-D87 cells also indicated that differentiation was unaffected by the introduction of SIRPa-WT or SIRPa-D87, suggesting that SIRPa was not regulating differentiation in general. Furthermore, SIRPa did not affect the upregulation of other myeloid differentiation markers, such as CD11b and CD14, during granulocytic or monocytic differentiation (not shown). The upregulation of endogenous SIRPa on PLB-985 cells coincided with that of gp91 phox at days 1-3 of neutrophilic differentiation ( Figure S3B ).
To demonstrate that gp91 phox was indeed the only relevant factor downregulated by SIRPa, gp91 phox was reconstituted by retroviral expression into SIRPa-WT cells ( Figure 2E ), and this resulted in a full restoration of the respiratory burst ( Figure 2F ). A similar restoration was observed when such reconstitution was performed in PLB-985 X-CGD cells. This shows that SIRPa suppresses phagocyte NADPH oxidase activity by a selective repression of gp91 phox protein expression during myeloid differentiation.
Inhibition of the NADPH Oxidase Involves Signaling via the SIRPa Cytoplasmic ITIMs
The experiments described above suggested that direct signaling through the cytoplasmic tail is involved in the regulation of the NADPH oxidase and gp91 phox protein expression. The SIRPa cytoplasmic tail harbors ITIMs responsible for the recruitment of the cytosolic tyrosine phosphatases SHP-1 and SHP-2 (Fujioka et al., 1996) . Studies with dominant-negative SHP-1 in myeloid cells (Dong et al., 1999) and with phagocytes from motheaten SHP-1-deficient mice (Kruger et al., 2000) demonstrated that at least SHP-1 acts as a negative regulator of the respiratory burst in myeloid cells. To investigate whether SHP-1 and/or SHP-2 recruitment by SIRPa plays a critical role in suppressing the respiratory burst by SIRPa, we mutated each of the four tyrosines from the SIRPa ITIMs, or combinations thereof, into phenylalanines and expressed the resultant proteins in PLB-985 cells. To evaluate the binding of SHP-1 and SHP-2 to the SIRPa mutants, we performed immunoprecipitation experiments. An analysis of the precipitates by western blotting demonstrated constitutive binding of SHP-1 and SHP-2 to SIRPa, and this was eliminated or at least strongly reduced by mutation of the ITIM tyrosines ( Figure 3A) . The same was observed in the reverse experiment, i.e., SHP-1 or SHP-2 immunoprecipitation followed by western blotting with SIRPa specific antibody (not shown). Mutation of all four ITIM tyrosines (SIRPa-Y1, SIRPa-Y2, SIRPa-Y3, and SIRPa-Y4F) completely restored the respiratory burst ( Figure 3B ) and gp91 phox protein expression ( Figure 3C ) to levels seen with the SIRPa-D87 cytoplasmic deletion mutant, suggesting that the ITIMs were responsible for the inhibitory activity. The level of inhibition obtained with the individual mutants correlated very well with their capacity to recruit SHP-1 and SHP-2. For instance, the membrane proximal Y1 appeared to be more important for the negative regulation of the NADPH oxidase than its membrane distal counterpart Y3. expression, mRNA levels were low in the cells that express the full-length SIRPa protein ( Figure 3D ), suggesting suppression of transcriptional activity of the gp91 phox /CYBB gene and/or increased mRNA turnover. There was a strong correlation among gp91 phox mRNA, protein, and NADPH oxidase activity. Finally, to investigate whether SIRPa expression and signaling also affected the intracellular microbial killing, we evaluated the various PLB-985 mutants for their capacity to kill intracellular Salmonella bacteria. Enhanced Salmonella outgrowth was observed in the PLB-985 X-CGD cells ( Figure S3C ), directly indicating a role for the NADPH oxidase in Salmonella killing. There was a good inverse relation between NADPH oxidase activity and intracellular bacterial survival ( Figure 3E ). For instance, the overexpression of SIRPa-WT tended to enhance bacterial survival, whereas the SIRPa-D87 cytoplasmic deletion mutant resulted in lower bacterial survival compared with that observed with the empty vector cells. Also, the various Y mutants displayed a pattern of microbial survival generally corresponding to their NADPH oxidase capacity. The various mutants displayed similar levels of Salmonella uptake ( Figure S3D) .
Collectively, these results show that SIRPa signaling via the ITIMs negatively regulates the respiratory burst by controlling the expression of gp91 phox . It should be noted that we have not yet been able to characterize the relevant downstream signaling pathway(s). Of note, two transcription factor complexes, ICSBP and HoxA10, were previously shown to play a key role in the regulation of gp91 phox gene expression, and both of these complexes are also subject to regulation by SHP-1 and/or SHP-2 (Zhu et al., 2008; Lindsey et al., 2007; Kautz et al., 2001 ). Both complexes are obvious candidates to mediate the effects of SIRPa signaling on gp91 phox gene expression, but our analysis of their activity by electrophoretic mobility shift assay in the cell panel studied here did not provide any evidence for their involvement (J.A.Z., unpublished data). We are currently exploring alternative possibilities.
Inhibition of the NADPH Oxidase by SIRPa Involves CD47-SIRPa Interactions
SIRPa has been shown to interact via its N-terminal Ig-like domain with the broadly expressed CD47 molecule, and the molecular basis for CD47-SIRPa interactions has been established by mutagenesis and crystallography Hatherley et al., 2008) . SIRPa ligation by CD47 triggers SIRPa ITIM phosphorylation and SHP-1 and/or SHP-2 recruitment and signaling, which in turn regulates downstream cellular responses. As indicated above, the observation that SIRPa mutants, such as the SIRPa-D87 and several of the ITIM tyrosine mutants, display an enhanced oxidase activity and gp91 phox expression suggested a dominant-negative effect. We anticipated that the rat extracellular domain of the chimeric SIRPa molecule that was introduced into the PLB-985 cells would compete with the endogenous human SIRPa for CD47 binding, thereby reducing inhibitory signaling through the latter. Indeed, PLB-985 cells expressed CD47 on their surface ( Figure 4A ), and CD47 expression levels were not significantly affected by The bars show total binding in the absence of antibodies, as well as the effects of preincubation with anti-rat SIRPa mAb ED9 alone (ED9-blockable), the calculated difference between preincubation with both mAb ED9 plus the anti-human mAb 7C2 and preincubation with ED9 (7C2-blockable), and preincubation with both ED9 and 7C2 mAb (remaining). See also Figure S4. expression of SIRPa or its mutants ( Figure S4A ). To directly address whether CD47-SIRPa interactions contribute to the inhibitory effect of SIRPa on the phagocyte respiratory burst, we constructed several SIRPa variants in which the extracellular ligand-binding domain was mutated. The mutants included deletions of the entire extracellular region (SIRPa-DECD), the N-terminal V-like Ig domain (SIRPa-DV), or a single point mutation V56M within the N-terminal V-like Ig region that was previously demonstrated to abolish CD47 binding . The resulting cell lines were analyzed by FACS with antibodies against rat and human SIRPa ( Figure S4A ) and western blotting ( Figure S4B ), and were found to express comparable surface levels of the various SIRPa molecules, with the expected sizes. In all of the cells with SIRPa extracellular domain mutations, the respiratory burst was strongly enhanced compared with empty vector controls, yielding activities close to those of the D87 mutant ( Figure 4B ). This suggested that similarly to the mutants that affected SIRPa signaling, the mutants that affected ligand binding were acting as dominant-negative molecules, and in addition were sequestering relevant downstream signaling molecules such as SHP-1 and/or SHP-2.
It was clearly important to demonstrate a direct interaction between the rat extracellular domains of our chimeric SIRPa constructs and human CD47. For this purpose, we generated a fusion protein of the extracellular domain of human CD47 and the Fc part of IgG1 (CD47-Fc), and developed a fluorescent bead assay to measure cellular CD47 binding. Analysis of the mutants demonstrated enhanced CD47 binding in SIRPa-WT cells as compared with empty vector cells ( Figure 4C ). This enhanced binding was prevented by blocking with the anti-rat SIRPa-specific mAb ED9, directly demonstrating that the chimeric rat-human SIRPa molecules are capable of binding human CD47. In addition, this analysis also demonstrated detectable CD47 binding by the endogenous human SIRPa that could be inhibited by the mAb 7C2. Analysis of the other mutants confirmed CD47 binding to SIRPa-WT, SIRPa-D87, SIRPa-Y1, SIRPa-Y2, SIRPa-Y3, and SIRPa-Y4 cells, but not to any of the SIRPa extracellular domain mutants ( Figure 4D) .
Collectively, these results indicate that CD47-SIRPa interactions contribute to the inhibitory activity of SIRPa on the respiratory burst. Clearly, we are formally unable to distinguish whether cis (i.e., on the same cell) and/or trans (i.e., between different cells) interactions are involved. However, considering the relatively low culture density of our cells and the low number of interactions between cells that occur during culture, we think it is most likely that the observed effects occur primarily as a result of cis interactions. However, it would seem that in the context of a hematopoietic tissue such as the bone marrow in vivo, where myeloid cells develop normally, the propensity for trans interactions would be much higher, and such interactions could also contribute to restricting gp91 phox expression.
Taken together, these results demonstrate that CD47-SIRPa interactions and ITIM-dependent downstream signaling via SIRPa control the magnitude of the phagocyte respiratory burst by regulating the expression levels of gp91 phox . We propose that CD47-SIRPa interactions participate in a homeostatic pathway that acts on developing phagocytes and functions to control excessive NADPH oxidase activity, and this serves to protect host cells and tissues against collateral oxidative damage during infection and other inflammatory conditions. Among the next challenges will be to provide insight into the mechanism(s) by which SIRPa-signaling regulates gp91 phox expression, and to establish a contribution of CD47-SIRPa-dependent regulation of the NADPH oxidase during inflammation and infection. The latter issue may not be straightforward to address, because other relevant processes, such as leukocyte transendothelial migration, may also be regulated by CD47 and SIRPa (Liu et al., 2002; de Vries et al., 2002) .
EXPERIMENTAL PROCEDURES
Mice, Cells, and Culture C57BL/6 mice with a targeted deletion of the SIRPa cytoplasmic region were described previously (Yamao et al., 2002) . PLB-985 and PLB-985 X-CGD cells (Zhen et al., 1993) , kindly provided by Dr. M. Dinauer (Indianapolis, IN, USA), were grown in RPMI 1640 medium supplemented with 10% (v/v) fetal bovine serum, 2 mM L-glutamine, 100 U/ml penicillin, and 100 mg/ml streptomycin (complete medium) at 37 C and 5% CO 2 . For granulocytic differentiation, the cells were exposed to 0.65% (v/v) DMF (Sigma-Aldrich, St. Louis, MO, USA) for 5-6 days. Monocytic differentiation was achieved by culturing in the presence of 100 nM VitD3 (1a, 25-dihydroxyvitamin D3; Sigma-Aldrich) for 5-6 days.
Measurement of Respiratory Burst Activity
Activity of the respiratory burst after PMA (Sigma-Aldrich) or STZ (ICN Biochemicals, Cleveland, OH, USA) stimulation in transduced PLB-985 or PLB-985 X-CGD cells was measured with the Amplex Red (10-acetyl-3,7-dihydroxyphenoxazine) Hydrogen Peroxide Assay kit (Molecular Probes, Eugene, OR, USA) as previously described (Kuijpers et al., 2007 
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